Medicure Incorporated (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, announced yesterday that it has named Dr Neil Owens as its new President and Chief Operating Officer, effective 1 July 2019.
Owens will be responsible for implementing the company's strategic plans, and managing day-to-day operations, including the advancement and management of new and existing pharmaceutical products.
Owens has worked at Medicure since 2014, serving most recently as Director, Scientific Affairs. Owens holds a Bachelor of Science and a PhD in Chemistry from the University of Manitoba and has Post Doctoral experience with the IECB.
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees